Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CorMedix (CRMD) Other Non-Current Assets: 2012-2024

Historic Other Non-Current Assets for CorMedix (CRMD) over the last 10 years, with Dec 2024 value amounting to $105,368.

  • CorMedix's Other Non-Current Assets rose 514.85% to $642,066 in Q2 2025 from the same period last year, while for Jun 2025 it was $642,066, marking a year-over-year increase of 514.85%. This contributed to the annual value of $105,368 for FY2024, which is N/A change from last year.
  • Per CorMedix's latest filing, its Other Non-Current Assets stood at $105,368 for FY2024, which was down 15.03% from $124,000 recorded in FY2022.
  • CorMedix's 5-year Other Non-Current Assets high stood at $191,000 for FY2020, and its period low was $105,368 during FY2024.
  • Its 2-year average for Other Non-Current Assets is $114,684, with a median of $114,684 in 2022.
  • Its Other Non-Current Assets has fluctuated over the past 5 years, first rose by 9.17% in 2020, then plummeted by 30.89% in 2021.
  • Yearly analysis of 4 years shows CorMedix's Other Non-Current Assets stood at $191,000 in 2020, then crashed by 30.89% to $132,000 in 2021, then decreased by 6.06% to $124,000 in 2022, then reached $105,368 in 2024.